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ABSTRACT
Objective Variable rate intravenous insulin infusions 
(VRIII) is a high- risk medication that has a potential to 
cause significant patient harm if used in error. Complex 
preparation of VRIII in clinical areas and the need for 
frequent monitoring and adjustment increase the 
complexity of using VRIII. An emerging approach, called 
Resilient Healthcare, proposes understanding complexity 
of work by exploring how work is assumed to be done 
and compare it with everyday work. This study aimed to 
explore how VRIII is perceived to be used by healthcare 
practitioners, focusing on one aspect of Resilient 
Healthcare: understanding how work is assumed to be 
done, using a method called hierarchical task analysis 
(HTA).
Design A qualitative study using document analysis and 
focus groups.
Setting A vascular surgery unit in an acute National 
Health Service teaching hospital in the UK.
Participants Stakeholders/users in different professional 
roles involved in the process of using VRIII.
Results The HTA showed the complexity of using 
VRIII and highlighted more than 115 steps required to 
treat elevated blood glucose. The process of producing 
hospital- specific guidelines was iterative. Careful 
consideration was taken to coordinate the development 
and implementation of guidelines. Documents provided 
detailed clinical instructions related to the use of VRIII but 
practitioners selectively used them, often in deference to 
senior colleagues. Intentional adaptations, for example, 
proactively asking for a VRIII prescription occurred and 
were acknowledged as part of providing individualised 
patient care.
Conclusion Using VRIII to treat elevated blood glucose 
is a complex but necessary process mediated by a range 
of factors such as organisational influences. Adaptive 
strategies to mitigate errors were common and future 
research can build on insights from this study to develop 
a broader understanding of how VRIII is used and to 
understand how adaptations are made in relation to the 
use of VRIII.
INTRODUCTION
Controlling blood glucose (BG) in hospital-
ised patients is very important for optimal 
patient outcomes. Globally, variable rate intra-
venous insulin infusions (VRIII) is considered 
the treatment of choice to achieve optimal 
BG levels in hospital inpatients who are not 
eatingand those with some acute illnesses, 
for example, sepsis.1 2 Studies reported in the 
scientific literature describe benefits from 
using VRIII to control elevated BG levels, 
including reduced mortality, less time spent 
in hospital and improved wound healing.3 4 
However, if used incorrectly, it can result in 
patient harm from hypoglycaemia, rebound 
hyperglycaemia and diabetic ketoacidosis.5
Complex systems and clinical complexity
Contemporary healthcare systems have been 
described as complex adaptive system (CAS) 
where components in a system act in a dynamic 
network, constantly react in unpredictable 
and non- linear ways resulting in the emer-
gence of outcomes 6 7 The level of complexity 
in healthcare systems has increased expo-
nentially with each new diagnostic, thera-
peutic and technological discovery.8 The use 
Strengths and limitations of this study
 ► To the best of our knowledge, this is the first study 
to explore Work As Imagined in relation to the use 
of variable rate intravenous insulin infusions (VRIII).
 ► Multiple data sources, that is, document analysis 
and focus group meetings were used to understand 
how work is imagined while using VRIII.
 ► This is the first study that used hierarchical task 
analysis to illustrate the tasks that were expected to 
be done while using VRIII.
 ► The low number of focus groups participants might 
not represent the perspectives of all the staff who 
might have given different views on the tasks of us-
ing VRIII.
 ► Discussions with focus groups participants about 
the guidelines that were implemented a few years 
ago may have been a potential source of recall bias.
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of VRIII is also complex and can result in unpredictable 
outcomes. A range of factors such as medication- related 
factors, for example, the limited evidence for a threshold 
for starting VRIII1; patient- related factors, for example, 
associated comorbidities9; provider- related factors, for 
example, fear of hypoglycaemia10; task- related factors, for 
example, frequent (hourly) BG monitoring1 and hospital- 
related factors, for example, complex and variable guide-
lines and staff shortages,9 contribute and influence the 
clinical complexity of using VRIII.
Safety in the use of VRIII
A variety of national and international interven-
tions and initiatives have been reported to improve 
the safety of using VRIII, including using advanced 
glucose monitoring technology that measures BG 
continuously and alerts for hypoglycaemia or hyper-
glycaemia episodes,11 specialist diabetes nurses,12 
the Think Glucose campaign,13 double checking, 
standardisation of VRIII guidelines, providing ready- 
to- administer injectable medications and extra educa-
tion and training for healthcare staff.14 In the UK, 
the Joint British Diabetes Societies for Inpatient Care 
(JBDS- IP) was established in 2008 to improve inpa-
tient diabetes care through standard setting and clin-
ical guidelines development.15 A recent audit assessed 
the breadth of the JBDS- IP guidelines’ adoption in 
the UK.15 It was found that 88% of the surveyed hospi-
tals adopted the VRIII guidelines for medical inpa-
tients, and around 58% of healthcare practitioners 
in these hospitals felt that the guidelines’ adoption 
had improved clinical outcomes and patient safety.15 
Despite the high adoption of the VRIII guidelines and 
other safety initiatives, the 2018 National Diabetes 
Inpatient Audit (NaDIA) revealed that the percentage 
of inappropriate use and duration of use of VRIII have 
not changed significantly since 2011 and that errors 
still persist.5 A possible explanation for this is that 
some traditional safety approaches, for example, stan-
dardised practice do not always take into account the 
constantly changing and complex nature of health-
care systems. Greenhalgh and Papoutsi illustrated 
the need to design and implement research methods 
that appreciate dynamic interactions and emergence 
in CASs, and understand from different perspectives 
how the whole system works.16 Recent safety literature 
shows a growing interest in what is called Safety- II, 
which advocates investigating how things go right 
instead of only focusing on how a particular failure 
had happened (Safety- I). Resilient Healthcare (RHC) 
acknowledges that variability in performance is inev-
itable. It does not argue for a total replacement of 
Safety- I with Safety- II, rather proposes that it is neces-
sary to focus on how everyday work can be performed 
successfully (what goes right) as well as how work 
has failed (what can go wrong) in order to improve 
safety.17 18 Various data collection methodshave 
been used to study RHC, including using the four 
capabilities of RHC, that is, respond, monitor, antic-
ipate and learn, investigating performance variability 
and Work As Done (WAD) and integrating RHC with 
other safety paradigms.17
Modelling ‘work as imagined’
Work is defined as a physical or cognitive effort/activity 
directed toward achieving a specific goal or task.19 
This study is part of a wider project for which there is a 
published protocol.20 There have been many research 
studies discussing the quality of different process model-
ling approaches.21 22 Although a sequential flow diagram 
is considered the most commonly used process mapping 
approach in healthcare, there have been precedents for 
using hierarchical task analysis (HTA) for analysing and 
mapping complex healthcare systems.23 24 An HTA is 
known as a prerequisite task analysis that is developed from 
general to specific. HTA answers what must the user know 
or do to achieve the goal.25 However, the sequential process 
map is developed step by step and linearly to answer what 
are the methods that the user must go through in order 
to complete a specific activity.26 Colligan et al conducted a 
study to examine the effect of a sequential flow diagram 
and HTA on the healthcare practitioner’s judgement. The 
results of that study found that HTA was easier to produce 
graphically and review as the mapping progressed, flexible 
in representing specific goals which did not correspond to 
specific acts or times, and encompassing unpredictability 
of healthcare activities with a focus on goal rather than 
the precise method. HTA is one of the most commonly 
used task analysis techniques27 to understand and analyse 
the complexity of the work. In this study, HTA was used 
to investigate work is imagined (WAI) in the use of VRIII 
from different perspectives. HTA was developed based on 
the theory of performance and has been used to describe 
system dynamics and human- system interfaces.28 HTA is a 
flexible and generic tool and has been applied in different 
domains25 27 such as in the process control and power 
generation industries and recently in medication adminis-
tration and management.29 30 The use of VRIII is driven by 
the need to identify and achieve the goal of patient care 
despite the variability in patients, availability of staff and the 
demands on the system.
Study aim
In this study, we aimed to systematically explore WAI 
when using VRIII from multiple perspectives. The find-
ings of this study may be the first step for healthcare 
practitioners and policy makers to create robust under-
standing of the reality of WAI to improve patient safety in 
relation to the use of VRIII.
METHODS
Study design
This research drew on the constructivism paradigm, which 
emphasises the importance of the context in the process 
of knowledge construction and accumulation.31 This 
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paradigm shaped our view of what type of knowledge about 
WAI would be of value.32 For the purpose of this study, a 
descriptive, systematic approach was applied to establish 
empirical data with a view to exploring how WAI in the 
use of VRIII.33 The researchers interpreted and analysed 
data from documents and focus groups (FGs) drawing on 
their own experiences, in order to construct a deep under-
standing of WAI as it is described in the guidelines and 
how practitioners think they use the VRIII guidelines. This 
study was conducted in three phases: (1) document anal-
ysis; (2) FG discussions; (3) the development of the HTA by 
merging of the data from both sources. Figure 1 illustrates 
the study phases to represent WAI in the use of VRIII.
Study setting
The study was conducted at the vascular surgery unit of an 
acute National Health Service (NHS) teaching hospital in 
the UK.
Phase 1: document analysis
All current hospital- specific documents that described 
key tasks related to the use of VRIII to treat elevated BG in 
adult in- patients, such as indications for use, prescribing, 
administration, monitoring, adjusting infusion rates and 
transition to other medication, and were readily available 
on the hospital’s intranet (see box 1), were included. 
These documents were used to develop understanding 




A purposive sample of stakeholders/users with different 
key responsibilities (guidelines developers, managers and 
healthcare practitioners) involved in treating elevated BG 
using VRIII were recruited. There is no definite sample 
size for qualitative research. It depends on a range of 
factors including the underpinning methodology, the 
scope of the research question, and the resources avail-
able.34 Summary information about FG participants’ 
characteristics can be found in Table 1.
Recruitment
Participant recruitment for the three FGs was undertaken 
over 6 months (December 2018–May 2019). Specifically, 
the hospital collaborator sent an email invitation letter and 
participant information sheet outlining the purpose of the 
study to potential participants for FGs 1 and 2. The clin-
ical and managerial leads sent an email invitation letter 
and participant information sheet for FG3. The researcher 
attended two ward meetings to meet as many healthcare 
practitioners as possible to explain the aim and methods of 
the study. Interested participants contacted the researcher 
directly via email. On the day of the FG and prior to the 
session, the researcher explained the study to the partici-
pants again, allowed time for any other questions they may 
have about the study and took informed consent.
Data collection
The three FG meetings took place in a quiet meeting 
room at the vascular surgery unit and lasted approxi-
mately 30–45 min, each. The research team, including 
the hospital collaborator, developed the FG topic guide 
(see online supplemental file 1). The topic guide was 
informed by the results of the document analysis. A topic 
guide included open- ended questions, and a case scenario 
Figure 1 Diagram summarising the three different phases of the study. VRIII, variable rate intravenous insulin infusions.
Box 1 Documents related to the use of variable rate 
intravenous insulin infusions (VRIII)
1. Guidelines for VRIII in adults.
2. Guidelines for management of diabetic ketoacidosis in adults.
3. Guidelines for management of hyperosmolar hyperglycaemic state 
in adults.
4. Managing diabetes in adult inpatients before, during and after op-
erations and procedures.
5. The management of hypoglycaemia in adult inpatients.
6. Hand hygiene policy.
7. Aseptic non- touch technique (peripheral and central access intra-
venous therapy).
8. Recording Line Insertion and Visual Infusion Phlebitis Score.
9. Patient identification policy.
10. Visual Infusion Phlebitis Score.
11. Procedure for preparing and administering injectable medicines.
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of treating elevated BG was used in all FG meetings to 
discuss the treatment plan based on their understanding 
of the VRIII guidelines used in their hospital. MHI (PhD 
candidate, pharmacist) moderated all the FG meetings. 
All meetings were audiorecorded, and the recordings 
transcribed verbatim.
Phase 3: data analysis
Data gathered from both documents and FG meetings 
were analysed using both inductive and deductive analyt-
ical approaches. The analysis began by analysing docu-
ments deductively, codes were determined based on the 
literature to provide details on the key tasks in the process 
of treating elevated BG using VRIII. Coding for the docu-
ments was conducted by a single researcher (MHI) with 
the aid of NVivo V.12, a qualitative data management 
software. Initial codes were then discussed within the 
research team (MHI, RL and KR) and mutually refined 
until they reached consensus.
After the initial stage of document analysis was completed, 
FG transcripts were analysed using both inductive and 
deductive analytical approaches. To enhance credibility, 
three of the authors participated in analysing the tran-
scripts. MHI, RL and KR independently coded the tran-
scripts. The three researchers discussed their codes until 
they reached consensus. Then codes from documents 
and FGs were constructed into candidate categories. For 
example, initial codes relating to preparing guideline were 
identified as ‘best practice’ (MHI), ‘consensus, no robust 
evidence’ (KR), and ‘contextualise the national guidelines’ 
(RL). Working together, MHI, RL and KR reinterpreted 
these codes into ‘understand the context’. The categories 
from both document analysis and FGs were combined and 
refined according to the HTA objectives of identifying the 
overall goals, subgoals, subtasks, operations and analysing 
plans to explain how goals were obtained. HTA develop-
ment comprised various steps, including defining task 
under analysis, determining the overall goal, determining 
task subgoals, breaking down subgoals until an appropriate 
operation was reached, and analysing plans to explain how 
goals were reached.27 The HTA was constructed using the 
Microsoft Visio Professional 2019 software.
Developing the HTA was an iterative process. The 
researchers identified and agreed on the task under anal-
ysis and the overall goals. Three key subgoals from both the 
documents and FG transcripts were identified, reflecting 
important patterns in helping to answer the research ques-
tion. Descriptions of subgoals were used to explain how 
goals were achieved. The draft HTA was validated with the 
wider research team and healthcare practitioners from 
the study hospital to establish the fit between the partici-
pants’ views and the researchers’ representation of the final 
HTA.35
Patient and public involvement
Patients and the public were not involved in the develop-
ment of the research question, study design, recruitment and 
conduct of the study.
RESULTS
The final HTA diagram is presented in Figure 2. The overall 
HTA goal resulting from our analyses and interpretation of 
the hospital documents and FG participants’ perspectives 
on how work was imagined in the use of VRIII, was to treat 
elevated BG in hospitalised patients using VRIII. Three key 
subgoals were identified: produce hospital- specific VRIII 
guidelines, implement the guidelines and use the guide-
lines. Each of these subgoals is presented individually, 
below. For clarity, representative quotations from partic-
ipants are reported below; additional quotations can be 
found in online supplemental files 2 and 3.
Produce hospital-specific VRIII guidelines
A multidisciplinary team, composed of diabetes/acute medi-
cine consultants, pharmacists and adult diabetes inpatient 
nurse specialists, was responsible for preparing hospital- 
specific VRIII guidelines. Producing guidelines took place 
in several iterative stages. ‘Preparing a first draft’ sub- goal 
was based on several resources such as the relevant JBDS- IP 
guidelines,2 the NaDIA,5 local incident reports, feedback, 
Table 1 Characteristics of focus groups (FG) participants
FG1 guidelines 
developers FG2 managers FG3 healthcare practitioners
Sample Diabetes consultants, 
pharmacist and diabetes 
specialist nurses.
Nurses (ward manager, deputy sister, diabetes 
nurse specialist and diabetes link nurse that is, 
registered nurse with an expressed interest in 
diabetes and a formal link to diabetes specialist 
team).
Foundation year doctors (medical 
graduates entering the medical workforce 
as ‘junior doctors’ on a 2- year work- based 
training programme) and Nurses (Sister/
Charge Nurse).
Role Develop and disseminate 
guidelines for the use of 
IV insulin infusions.
Implement guidelines, allocate resourcesand staff 
training. Diabetes Link Nurse acts as a conduit 
between front line practitioners and the inpatient 
diabetes specialist team.
Work at the vascular surgery unit using 
intravenous insulin infusions and do not 
have a management role.
No of potential 
participants
4 10 20
No of recruited 
participants (%)
4 (100) 3 (30) 4 (20)
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audits, quality improvement (QI) projects and intuition. 
FG1 data showed that all participants perceived ‘reviewing 
the clinical content and context by multidisciplinary team’ 
to be vital. Although the JBDS guidelines were used as the 
standard as they are considered best practice, it was clear 
that the hospital did not solely rely on these guidelines.
‘That draft was based on loads of previous proformas 
and sequential learning and then when we done that 
we initially sent it round our Think Glucose…. So there 
is not necessarily a really a robust evidence base or, if 
you look at the JBDS… some of the ones where we 
could not just follow the template guidelines verbatim’. 
FG1
The hospital used different resources (eg, consulting the 
Think Glucose Group, which is a multidisciplinary group 
of healthcare professionals at the study hospital concerned 
with inpatient diabetes, an inpatient specialist nursing 
team who have extensive hands- on experience, and junior 
doctors) to adapt the national guidelines to make it rele-
vant to their hospital. The guidelines were ‘live’ documents 
and underwent review, revision and then approved by a 
committee when required, in appropriate situations.
Implement the guidelines
Second, implement the guidelines started from a formal 
‘launch’ of the electronic prescribing and laboratory test 
care bundle (PowerPlan). This progressed in parallel with 
widespread communication by ‘making the guidelines avail-
able on the hospital intranet’ and accessible to all practi-
tioners, followed by ‘training’ relevant staff about the new 
guidelines. The importance of informing relevant staff was 
recognised where ‘launch’ consisted of several subgoals. The 
subgoal ‘prepare staff group- specific material’ was described 
by participants in all three FGs. This involved, for example, 
the adult diabetes inpatient nurse specialists providing a fact 
sheet to the link nurses, inviting them to explain the rationale 
of changes made to other nurses. Matrons also sent memos 
and emails to ward sisters requesting they inform all staff of 
the new changes.
‘… so he [link nurse] would go to the ward meeting 
and say this is happening.…, the ward sister, may get 
a memo from her matron saying please can you get 
all your staff to revisit this policy? We'd also have ward- 
based training. So it isn't just one thing, it’s differ-
ent methods of reinforcing a change of practice or a 
change of policy’. FG2
Figure 2 Hierarchical task analysis diagram of the process of treating elevated BG using VRIII. #FG1; *FG2; ˆFG3. APP, 
as per policy; BG, blood glucose; EPMA, Electronic Prescribingand Medicines Administration; IV, intravenous; JBDS, Joint 
British Diabetes Societies; MMTC, Medicine Management Therapeutics Committee; NaDIA, National Diabetes Inpatient Audit; 
PowerPlan, Electronic prescribing and laboratory testbundle based on the local hospital guidelines; QI, Quality Improvement.
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‘Train staff how to use the guidelines’ was another major 
subgoal in the task of implementing guidelines. To accom-
plish this subgoal:
 ► The guideline developers ensured that new junior 
doctors were taught how to prescribe VRIII. As the task of 
prescribing VRIII is complicated, the junior doctors were 
asked to use the PowerPlan, which was based on the local 
hospital guidelines. In addition, the doctors sometimes 
followed a hyperlink on the PowerPlan to access the full 
guidelines.
 ► Healthcare practitioners indicated that doctors were 
provided with a generic induction handbook not specific 
to VRIII as part of the training process when they joined 
the vascular surgery unit.
 ► Diabetes Link Nurses and ward sisters provided a 
brief (10 min) ward- based training covering three 
main points on a topic related to in- hospital diabetes 
management.
 ► The consultant body used medical grand round meet-
ings to inform doctors about the latest changes and 
to discuss the rationale of new guidelines (eg, Hyper-
osmolar Hyperglycaemic State) and provide further 
information around them.
 ► Feedback was sought within 2 months of imple-
menting the new guidelines, to identify any problems 
that had arisen, with responses being provided in 
separate communications.
 ► Update on Diabetes Link Nurse study days: the Diabetes 
Link Nurses were asked general questions and specifically 
probed about areas such as how often they managed to 
complete BG monitoring, where compliance might be 
difficult and to ascertain whether it was achievable, such 
as how often they managed to complete BG monitoring.
This way of training was used to gather as much feed-
back as possible in order to gain awareness of the prob-
lems practitioners faced and to devise solutions to them. 
It was clear from the three FGs that practitioners learnt by 
observing the practice of senior practitioners. The training 
and teaching relating to new practices happened through 
cascading—the ‘chain of influence’ technique36 by which 
staff influenced one another in making decisions and 
resolving disagreements.
‘…I think we found out that we don’t have the time or 
the staff to sit down for an hour and provide in- depth 
teaching to someone so [they've] started this what they 
call espresso teaching’. FG3
Use the guidelines
To accomplish this subgoal, almost all participants 
stated that staff are expected to follow the guidelines 
to ‘deliver appropriate patient care’. As delivering 
patient care was perceived to have a direct conse-
quence on patients’ BG treatment, deliver patient 
care was further decomposed to ten sub- goals, using 
data from analysing the 11 documents related to the 
use of VRIII. The ten subgoals were ‘complying with 
infection control precautions’, ‘identify patient’, 
‘gather patient information’, ‘identify the diagnosis’, 
‘prescribe’, ‘assemble components of VRIII’, ‘admin-
ister’, ‘monitor’, ‘refer for specialist diabetes advice’ 
and ‘confirm suitability to stop VRIII’. HTA diagrams 
for each sub- goal can be found in online supple-
mental file 4. The documents were clear and compre-
hensive and contained details about the aim, scope, 
responsibilities, training and monitoring compliance 
with precautions relating to specific tasks. There 
were, however, a lack of clarity in a couple of docu-
ments. In ‘The Management of Hypoglycaemia in 
Adult Inpatients Guidelines’, for example, when and 
at what rate to restart VRIII after managing hypo-
glycaemia was unclear. In ‘Guidelines for VRIII in 
Adults’, there was inconsistent guidance for example, 
it was stated to ‘continue VRIII for one hour after 
the subcutaneous insulin (SC) has been administered 
to allow time for the insulin to be absorbed’, while 
in the summary page it was recommended to ‘stop 
intravenous insulin at time of first prescribed dose’ 
of SC insulin. One of the guideline developers was 
contacted and this inconsistency was rectified. Partic-
ipants in each FG discussed a variety of ways that 
are used to review patient care, such as QI projects, 
audits, comments and feedback from practitioners, 
and local incident reports.
Almost all participants agreed that the number of devi-
ations from prescribed practice in the hospital was low. 
FG1 participants highlighted various situations in which 
healthcare practitioners might deviate, such as new doctors 
coming from a different Trust that have different guide-
lines, intentional deviations based on specialist advice 
related to a patient’s case, difficulty with hourly monitoring 
for VRIII (resulting in monitoring being done every 2 hours 
instead of every hour), and the active choice to discontinue 
long- acting insulin when using VRIII. Unintentional devi-
ation might occur because of challenges within the Elec-
tronic Prescribing and Medicines Administration (ePMA). 
For example, the FG1 participants highlighted that nurses 
were unclear about the order that prescribed intravenous 
fluids should be administered. As the ePMA system is not 
designed to show the order in which fluids are to be admin-
istered, FG1 participants emphasised the importance of a 
separate flow sheet to remind practitioners of the order in 
which to administer intravenous fluids. FG1 participants 
respond to deviations by having conversations and asking 
questions to identify the reasons behind the deviation, 
giving feedback, finding a compromise, providing imme-
diate informal education, and finally changing the wording 
of guidelines if required. If deviations become a pattern, 
the Diabetes Specialist Team would conduct localised 
education in the ward and modify the content of manda-
tory training materials.
‘So the insulin, you know the safe use of insulin is manda-
tory. Training has been modified based on incident and 
patterns that we see, so serious incidence and patterns 
that we see’. FG1
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DISCUSSION
The HTA showed the complexity of using VRIII by high-
lighting more than 115 steps required to achieve the key 
goal of treating elevated BG using VRIII. While HTA is 
typically applied to represent what people do,29 37 HTA was 
used in this study to explore the process of treating elevated 
BG using VRIII. The HTA illustrated how the use of VRIII 
was expected to be done, and how practitioners use VRIII 
in a wider system in a hierarchy of goals. The study high-
lighted three key subgoals.
Produce hospital-specific VRIII guidelines
Producing hospital- specific VRIII guidelines was iterative 
and inclusive, with different specialities and committees 
included. Almost all participants described the documents 
as very practical, clear and user- friendly. The documents 
contained clear details about the aim, scope, responsi-
bilities, training and monitoring compliance for specific 
tasks but the documents were written in a technical way 
that not every novice can understand unless they are very 
well experienced in hospital work generally and insulin 
use specifically. The comprehensive documentation could 
inadvertently result in a negative effect, as the large number 
of documents related to VRIII could confuse healthcare 
practitioners. Consistent with previous studies,38 39 however, 
the importance of this comprehensiveness should not be 
underestimated; it serves as a backup and has a positive 
effect on patient safety by providing practitioners with all 
the information they need for using VRIII.
Implement the guidelines
The training and teaching around new changes to guide-
lines happens by cascading the ‘chain of influence’ 
technique, in which members influence one another in 
making decisions and resolving disagreements.36 This way 
of training can be expressed as applying tacit knowledge, 
including skills, experiences, intuition and judgement, 
that is difficult to transfer to another person by means of 
writing it down or verbalising it.40 While there was agree-
ment that the hospital environment was very supportive in 
terms of training and education, there was a mix of proac-
tive and reactive approaches to training new staff. If new 
staff did not know how to use VRIII, senior staff would 
train them. Senior staff would inform front- line practi-
tioners about new changes or the training they needed 
with front- line practitioners often taking on a passive role. 
The current study showed that specific teaching sessions 
for junior doctors on using PowerPlan to prescribe VRIII 
were an essential part of the guidelines’ implementation 
process to ensure patient safety while using VRIII. Lack of 
knowledge is one of the key barriers in delivering appro-
priate diabetes care.41 42 An interventional controlled 
multicentre study was conducted to assess the impact 
of a strategy focused on educating healthcare practi-
tioners. The strategy’s impact on the quality of care was 
limited and there was no significant difference between 
controlled and interventional hospitals’ education strat-
egies for changing practitioners' behaviour.43 Similarly, 
a systematic review conducted by Bain et al concerning 
educational interventions to improve prescribing perfor-
mance, concluded that education was an important part 
of QI strategies in insulin prescribing; however, it was less 
effective when used in isolation.44 It can thus be suggested 
that further work is needed that directly evaluate the effec-
tiveness of the educational strategies used in the study 
hospital by exploring how challenging it is to achieve and 
sustain behaviour change.
Use the guidelines
The majority of the FG participants highlighted the 
importance of following the guidelines in order to deliver 
appropriate patient care while using VRIII. This finding is 
consistent with that of Sampson and Jones who concluded 
that the growing use of the JBPD- IP guidelines since 2011, 
has resulted in harm reduction related to the number of 
hypoglycaemic events and the unnecessary use of insulin 
infusions.15 Many studies described various challenges 
with the use of VRIII such as the risk of hypoglycaemia, 
frequency of monitoring, insufficient nurse- to- patient 
ratio and confusion about the target BG level.9 10 45 In 
contrast to previous studies, participants only mentioned 
two main challenges: sequence of administering intrave-
nous fluids, and frequency of BG monitoring. On the one 
hand, the findings might not represent all the challenges 
healthcare practitioners face at hospital; on the other, the 
results are not necessarily transferable to all the vascular 
surgery unit healthcare practitioners and the whole Trust.
The general conclusion of earlier evaluations of ePMA 
systems in hospitals has been that they can improve quality, 
not least by reducing medication prescribing and admin-
istration errors.46–48 However, one recent study found that 
although pharmacists valued a number of safety features 
associated with ePMA, they also perceived an overall 
increase in medication risk.49 In a retrospective audit of 
VRIII comparing ePMA with bespoke paper proforma, 
there was improved completion of tasks where prompts 
were inbuilt but in other areas, completion rates were 
inconsistent.50 This study found that nurses do not usually 
refer to the guidelines and doctors use the PowerPlan 
feature within the ePMA when prescribing. The fact that 
doctors usually rely on the ePMA might have mixed conse-
quences. On one hand, it might save time in prescribing, 
as doctors are busy. On the other, if the ePMA system is not 
working for example, freezes, safety challenges might rise 
such as delaying patients receiving their medications and 
affecting the efficiency of ward rounds.
Prescribing intravenous fluids is a complex and an ever 
changing situation in which indication, fluid type, volume 
and rate depend on the pathophysiological changes that 
affect fluid balance in disease states.51 52 In this study, 
prescribing intravenous fluids on the ePMA found another 
layer of complexity which was the lack of clarity about the 
order in which prescribed intravenous fluids should be 
administered. This result is in line with one study which 
found that some medications, such as insulin and intra-
venous fluids, were not safely prescribed using the system 
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because their protocols did not fit easily into the struc-
tures embedded in the software.53
The availability of a fully staffed diabetes inpatient 
team is recommended to enhance patient safety and 
reduce insulin prescribing errors.54 It has been suggested 
that the introduction of specialist diabetes pharmacists 
can support the implementation of insulin- prescribing 
interventions and decrease the percentage of insulin 
prescribing errors.55 In this study, although the role of 
specialist diabetes nurses was reported in all the activities 
required to treat elevated BG using VRIII, nothing was 
mentioned about the role of specialist diabetes pharma-
cists in treating elevated BG using VRIII.
Adaptations to work was part of everyday work. Although 
the general thinking between participants was about errors 
and how to avoid them (Safety I), guideline developers 
explicitly acknowledged the occurrence of intentional 
deviation from guidelines, as patients’ treatment should 
be individualised based on their situation. Nurses usually 
anticipate the needs of patients prior to surgery and some-
times proactively ask for a VRIII prescription, but doctors 
do not always provide such prescriptions as doing so may 
not be appropriate for the patient. There seems to be a 
need for careful thinking about flexibility and trade- offs 
in practice, and to set and define patient safety bound-
aries. These results reflect those of Vos et al, which showed 
that some behaviours that might be considered deviations 
from best practice when administering intravenous infu-
sions resulted from reasoned clinical judgement by nurses 
with the aim of improving patient care.56
The HTA provided a better understanding from 
multiple perspectives of the use of VRIII, and of organ-
isational influences such as how policies and guidelines 
were written, what was permitted, and how mandatory 
training was expected to be conducted. These results 
are broadly consistent with those of Raduma- Tomàs et 
al, who found that the application of the HTA provided 
a detailed description of the doctors’ handover process, 
enabled the identification of strengths and weaknesses in 
the performance of handover activities, and allowed for 
specific problems to be targeted for improvement.57 HTA 
has been used in health information technology by modi-
fying existing designs or creating new ones.58 59 Roosan 
et al used HTA and interactive infographics to develop a 
mobile prototype designed to deliver the patient package- 
insert information for the medication risperidone in an 
interactive way that helped patients gain an improved 
overall knowledge of the medication.58 Another study 
used HTA to assess the effect of implementing new health 
information technology on the workflow of the medi-
cation administration process.60 Its analysis of the HTA 
diagrams resulted in providing 15 recommendations for 
healthcare facilities to facilitate the transition to the new 
health information technology system.60 The developed 
HTA could serve as an effective form of system documen-
tation, enable guidelines developers to redesign guide-
lines and protocols based on the developed HTA, and 
help software engineers to gain familiarity with the tasks 
required while using VRIII in a systematic way which may 
enhance the design and usability of electronic systems as 
well as their ability to support individual/organisational 
contexts of use.
Clinical implications
WAI surrounding the use of VRIIIs was mainly related to 
the production, implementation and use of VRIII guide-
lines used in the study hospital. As the guidelines were 
implemented and used as part of the ePMA system, system 
designers in the study site may be able to use the devel-
oped HTAs to understand which trigger point of clinical 
care they can use to change and improve patient safety. For 
example, the study found that the ePMA system was not 
designed to show nurses the order in which fluids need 
to be administered—which makes it difficult for nurses to 
make the appropriate decisions. System designers might 
reduce the confusion by redesigning the ePMA system in 
a way that would enable doctors to prescribe intravenous 
fluids in a certain order and nurses to receive intravenous 
fluids prescriptions as graphs plotted from a timeline 
perspective.61 Data visualisation can reduce cognitive load 
and the amount of information needed to be searched 
before making decisions.62 63 A recent study found that 
developing a web- based timeline software, that graphically 
displays administered medication (y- axis) against time 
(x- axis), improved healthcare practitioners' interactions 
with the medical record system.63 The graphical time-
line software allowed healthcare practitioners to click on 
a medication name to display specific dosing and timing 
which resulted in reducing the time spent on medication 
review and easing the viewing of medication administra-
tion.63 In the study site, developing an intravenous fluids 
graphical timeline software that shows the order of admin-
istering the prescribed intravenous fluids may reduce 
the confusion in administering intravenous fluids and 
improve confidence in deciding the order of intravenous 
fluids administration without delay.
Another example of a trigger point of care that might 
be improved is the task of frequent BG monitoring, espe-
cially given the growing challenges facing the NHS, for 
example, the shortage of healthcare practitioners and the 
current pressure forced on healthcare practitioners by 
the Coronavirus (COVID-19) pandemic,64 65 which makes 
it difficult for this task to be conducted hourly. Evidence 
suggests that in- hospital use of continuous glucose moni-
toring (CGM) provides a practical alternative to frequent 
inpatient fingerstick testing. CGM works by inserting a 
sensor subcutaneously to measure the glucose level in the 
interstitial fluid, and results are provided every 5–10 min, 
24 hours a day.64 CGM incorporates predictive alerts for 
hypoglycaemia or hyperglycaemia which can be directly 
integrated into the electronic health record to alert the 
healthcare practitioners before the glucose sensor reaches 
the low or high threshold.66 Considering the implementa-
tion of this technology may decrease the burden of glucose 
monitoring for healthcare practitioners and decrease the 
risk of hypo/hyperglycaemia events.
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Strengths and limitations
The application of HTA revealed the importance of 
in- depth understanding of how WAI and how guidelines 
are used to treat elevated BG using VRIII. Methodolog-
ically, this is the first study to explore WAI in relation to 
the use of VRIII using the HTA. Future research can build 
on insights from the study findings, and indicate how 
and where within the BG treatment process safety chal-
lenges might occur, thus allowing for specific challenges 
to be targeted and extraordinary work/adaptations to be 
highlighted to improve patient safety when using VRIII. 
Limitations associated with this study include the subjec-
tivity of the healthcare professionals who participated in 
the FGs. The low number of staff who participated, espe-
cially in FGs 2 and 3, means that this analysis may not 
represent the perspectives of all the staff who use VRIII. 
Other participants might have given different views on the 
process of using VRIII. However, by purposive sampling of 
a diverse range of practitioners, this risk may have been 
somewhat mitigated. The purpose of qualitative studies is 
not to replicate or generalise the findings, however, qual-
itative studies are concerned with credibility and transfer-
ability.67 Although the results from qualitative studies of 
small sample size may not always statistically represent the 
whole population of interest; they are qualitatively trans-
ferable. In this study, credibility and transferability were 
ensured by using a member check technique to confirm 
the accuracy of the developed HTAs, data triangulation 
using two data sources (documents and FGs) and thor-
ough, detailed description of the contexts relating to the 
use of VRIIIs and the participants' accounts. Finally, it is 
necessary to acknowledge that guidelines discussed in this 
study were implemented a number of years ago and partic-
ipants were not given a topic guide prior to the discussions 
hence there could be recall bias. In hindsight, it would be 
better to provide participants with key discussion topics, 
so they have time to consider past events before the FG 
meetings.
CONCLUSION
This study set out to understand from various perspectives 
how VRIII were expected to be used to treat elevated BG 
in the clinical environment. Using the HTA methodology, 
a detailed and systematic description of the tasks needed 
to use VRIII was successfully developed. The novel explo-
ration of WAI within this context has important implica-
tions, revealing that the tasks required to treat elevated 
BG using VRIII are far more complex than merely imple-
menting and adhering to national guidelines. Specifi-
cally, the complexity was found in various tasks/subtasks 
including understanding the context, prescribing intra-
venous fluids using ePMA and BG monitoring frequency. 
These complexities have been shown herein to play a key 
role and have possible broader implications in different 
healthcare context with similar challenges. Various strate-
gies were expected to be used to enhance safety while using 
VRIII, among them training and intentional deviations/
adaptations. However, further work is required to extend 
the scope for understanding how VRIII is used by assessing 
the impact and efficacy of the reported strategies on the 
actual process of using VRIII. The study results provided a 
deep understanding of the reality of WAI. The next stage 
is to conduct video observations20 in order to understand 
how guidelines are used in practice, situations where the 
guidelines could not be delivered as written, type of chal-
lenges and context- dependent adaptations and to explore 
the gap/misalignments between WAI and WAD in order 
to find strategies to minimise the gap to improve patient 
care delivery.
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